FDA warns of kidney damage linked to bowel-cleansing agents
This article was originally published in Scrip
Executive Summary
Under new authorities provided by the FDA Amendments Act of 2007, the US FDA has ordered the addition of a "boxed warning" to two phosphate-based bowel cleansing agents used before colonoscopies because they have been linked to acute phosphate nephropathy, a rare but serious type of acute kidney injury.